Stay updated on GMI-1271 Combo with Chemo in AML Clinical Trial

Sign up to get notified when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GMI-1271 Combo with Chemo in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, pharmacokinetics, and efficacy evaluation of GMI-1271 in combination with chemotherapy for acute myeloid leukemia.
    Difference
    0.2%
    Check dated 2024-06-06T14:16:31.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying conditions such as AML diagnosis, age, prior treatments, and health status. This change provides more specific information about who can participate in the study.
    Difference
    21%
    Check dated 2024-05-22T20:26:35.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:56:27.000Z thumbnail image

Stay in the know with updates to GMI-1271 Combo with Chemo in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GMI-1271 Combo with Chemo in AML Clinical Trial page.